ICL Group에 대한 매도 수량은 투자자에게 ICL Group의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

ICL Group (NYSE:ICL) 주식, 공매도 수량 보고

ICL Group

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North and South America, and the Rest of the world.

Equities

Markets

ETFs

ADRT

ARGT

BSAC

DFEN

DXYZ

GOLD

JCPB

NUSI

UPRO

XPER

뉴욕 증권 거래소(NYSE)의 여러 주식들은 기술적 문제로 인해 월요일 동부 표준시 오전 9시 40분 이후 갑자기 거래가 중단되었다. 이번 예상치 못한 거래 중단은 일반적으로 단일 주식의 과도한 변동성을 억제하는 데 사용되는 &#34;상향 한도(Limit Up)/하향 한도(Limit Down)&#34; 코드로 분류된 기술적 문제로 인해 촉발되었다.

버크셔 해서웨이, 치폴레 등 뉴욕 증권 거래소 기술적 문제로 일시 거래 중단 발생

ICL Group Ltd

INTERCLOUD SYSTEMS by InterCloud Systems, Inc.

InterCloud Systems Inc

iClick Interactive Asia Group Limited - American Depositary Shares

iClick Interactive Asia Group Ltd

iShares Global Clean Energy ETF

Invesco Actively Managed Exchange-Traded Fund Trus Invesco AAA CLO Floating Rate Note ETF

Icon PLC

GreenFirst Forest Products Inc

GREENFIRST FOREST PRD NEW by GreenFirst Forest Products Inc. NEW

WIIM

Shares of fertilizer and potash stocks are trading higher on reports suggesting potash supplier Belaruskali cut production

Barclays analyst Benjamin Theurer upgrades ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) from Underweight to Equal-Weight and raises the price target from $4 to $6.

News

Upgrades

Price Target

Analyst Ratings

Barclays Upgrades ICL Group to Equal-Weight, Raises Price Target to $6

Company continues to expand global presence in battery materials space
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.icl-group.com%2F&amp;esheet=54181805&amp;newsitemid=20250116261144&amp;lan=en-US&amp;anchor=ICL&amp;index=1&amp;md5=20d38fb8e438f5aeb23fc33cf78eabdb">ICL</a> (NYSE:<a href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) (TASE: ICL), a leading global specialty minerals company, today announced it has signed a joint venture (JV) agreement with <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fdynanonic.com%2Fenindex.aspx&amp;esheet=54181805&amp;newsitemid=20250116261144&amp;lan=en-US&amp;anchor=Shenzhen+Dynanonic+Co.%2C+Ltd.&amp;index=2&amp;md5=245fb7628f2460dace062849ee85d2e2">Shenzhen Dynanonic Co., Ltd.</a> to establish lithium iron phosphate (LFP) cathode active material (CAM) production in Europe, with an initial investment of approximately &euro;285 million. A new facility at ICL&#39;s Sallent, Spain, site is currently in planning stages and will substantially expand the company&#39;s battery materials business. The project demonstrates ICL&#39;s commitment to developing high-quality solutions for a sustainable supply chain and represents a significant step forward for the company&#39;s battery materials portfolio, this time into Europe.

Contracts

ICL Expands Joint Venture With Shenzhen Dynanonic With Additional Investment Of €285 Million For European LFP Cathode Material Production

ICL Appoints Elad Aharonson As President And CEO, Effective March 13, 2025

Management

General

ICL Announced That Raviv Zoller, The Company's President And CEO For The Past Seven Years, Is Expected To Leave In Early 2025, Following The Appointment Of A Replacement And A Formal Transition

ICL Group shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results and raised its FY24 specialties-driven EBITDA guidance.

<h3>Companies Reporting Before The Bell</h3>
• Global Ship Lease (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSL#NYSE">GSL</a>) is projected to report quarterly earnings at $2.41 per share on revenue of $174.31 million. 
• Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) is projected to report quarterly earnings at $0.63 per share on revenue of $246.09 million. 
• Aramark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARMK#NYSE">ARMK</a>) is likely to report quarterly earnings at $0.53 per share on revenue of $4.46 billion. 
• ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $2.03 billion. 
• Lincoln Educational Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $110.77 million. 
• Strawberry Fields REIT (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STRW#AMEX">STRW</a>) is estimated to report earnings for its third quarter. 
• Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) is projected to report quarterly earnings at $0.38 per share on revenue of $140.07 million. 
• Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) is projected to report quarterly loss at $1.28 per share on revenue of $2.36 million. 
• GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) is estimated to report earnings for its third quarter. 
<h3>Companies Reporting After The Bell</h3>
• Grab Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) is expected to report quarterly loss at $0.01 per share on revenue of $691.80 million. 
• Ispire Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPR#NASDAQ">ISPR</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $52.81 million. 
• Talos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TALO#NYSE">TALO</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $500.03 million. 
• Team (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) is estimated to report earnings for its third quarter. 
• Mineralys Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLYS#NASDAQ">MLYS</a>) is expected to report earnings for its third quarter. 
• Live Nation Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>) is likely to report quarterly earnings at $1.71 per share on revenue of $8.09 billion. 
• Gatos Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GATO#NYSE">GATO</a>) is projected to report earnings for its third quarter. 
• Yalla Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YALA#NYSE">YALA</a>) is likely to report earnings for its third quarter. 
• Archrock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AROC#NYSE">AROC</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $283.55 million. 
• Ampco-Pittsburgh (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AP#NYSE">AP</a>) is likely to report earnings for its third quarter. 
• FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $30.69 million. 
• Bioceres Crop Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOX#NASDAQ">BIOX</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $120.80 million. 
• RMR Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMR#NASDAQ">RMR</a>) is estimated to report quarterly earnings at $0.38 per share on revenue of $220.35 million. 
• Assertio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASRT#NASDAQ">ASRT</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $28.87 million. 
• Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) is projected to report quarterly loss at $0.28 per share on revenue of $1.04 million. 
• Bridger Aerospace Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAER#NASDAQ">BAER</a>) is estimated to report quarterly earnings at $0.46 per share on revenue of $57.50 million. 
• Aterian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>) is expected to report quarterly loss at $0.55 per share on revenue of $26.01 million. 
• QuickLogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUIK#NASDAQ">QUIK</a>) is likely to report quarterly loss at $0.05 per share on revenue of $4.20 million. 
• VAALCO Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGY#NYSE">EGY</a>) is estimated to report quarterly earnings at $0.17 per share on revenue of $145.89 million. 
• Assured Guaranty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGO#NYSE">AGO</a>) is projected to report quarterly earnings at $1.36 per share on revenue of $201.37 million. 
• Stereotaxis (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STXS#AMEX">STXS</a>) is likely to report quarterly loss at $0.05 per share on revenue of $7.10 million. 
• NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $3.00 million. 
• Luminar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) is expected to report quarterly loss at $0.17 per share on revenue of $18.68 million. 
• James River Gr Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $146.56 million. 
• Crescent Capital BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCAP#NASDAQ">CCAP</a>) is estimated to report quarterly earnings at $0.57 per share on revenue of $48.69 million. 
• IAC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) is estimated to report quarterly loss at $0.28 per share on revenue of $923.69 million. 
• Angi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGI#NASDAQ">ANGI</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $298.54 million. 
• Intevac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVAC#NASDAQ">IVAC</a>) is expected to report quarterly loss at $0.15 per share on revenue of $11.50 million. 
• Nevro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVRO#NYSE">NVRO</a>) is likely to report quarterly loss at $0.81 per share on revenue of $93.07 million. 
• Zeta Global Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) is likely to report quarterly earnings at $0.17 per share on revenue of $248.65 million. 
• DoubleDown Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDI#NASDAQ">DDI</a>) is estimated to report quarterly earnings at $0.55 per share on revenue of $85.43 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

ANGI

ARMK

AROC

ASRT

ATER

BAER

BIOX

CCAP

GATO

GRAB

ISPR

IVAC

JRVR

LAZR

LINC

MLYS

MNDY

NPWR

NUWE

NVRO

QUIK

SPNS

STRW

STXS

TALO

TISI

XAIR

YALA

ZETA

Earnings Scheduled For November 11, 2024

The company raised its guidance for full year 2024 and now expects specialties-driven EBITDA of between $0.95 billion to $1.05 billion, an increase from previous guidance of $0.8 billion to $1.0 billion. The company intends to limit its total 2024 annual potash sales volumes to 4.6 million metric tons, already committed, which is in-line with 2023 sales volumes and in expectation of improved conditions in 2025.

Guidance

ICL Raised Its FY24 Guidance For Specialties-Driven EBITDA To $0.95B-$1.05B From $0.8B-$1B

ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.08 by 37.5 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.753 billion which missed the analyst consensus estimate of $1.788 billion by 1.98 percent. This is a 5.85 percent decrease over sales of $1.862 billion the same period last year.

Earnings Beats

Earnings Misses

ICL Group Q3 2024 Adj. EPS $0.11 Beats $0.08 Estimate, Sales $1.753B Miss $1.788B Estimate

ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) is preparing to release its quarterly earnings on Monday, 2024-11-11. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect ICL Group to report an earnings per share (EPS) of $0.09.
Anticipation surrounds ICL Group's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings History Snapshot</h3>
Last quarter the company beat EPS by $0.02, which was followed by a 0.95% increase in the share price the next day.
Here's a look at ICL Group's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.08</td>
<td>0.09</td>
<td>0.08</td>
<td>0.10</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.10</td>
<td>0.09</td>
<td>0.10</td>
<td>0.11</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-1.0%</td>
<td>4.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1731074516_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of ICL Group were trading at $4.23 as of November 07. Over the last 52-week period, shares are down 10.0%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/ICL/earnings">To track all earnings releases for ICL Group visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ICL Group's Earnings: A Preview

Company signs MOU to supply key component for production of LiPF6 battery materials
ICL (NYSE:<a href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) (TASE: ICL), a leading global specialty minerals company, today announced it has signed a memorandum of understanding (MOU) with Orbia Advance Corp., S.A.B. de C.V. (BMV:<a class="ticker" href="https://www.benzinga.com/stock/ORBIA#BMV">ORBIA</a>) Fluor &amp; Energy Materials (OF&amp;EM), as both companies continue to expand their presence in the North American battery materials supply chain. The MOU provides a framework for ICL's Industrial Products division to supply phosphorus trichloride (PCl3) to OF&amp;EM for its use in the production of LiPF6 – a critical raw material for lithium-ion batteries – at its planned St. Gabriel, La., manufacturing plant. ICL produces PCl3 at its plants in Gallipolis Ferry, W.Va., and in Bitterfeld, Germany, and is considered a leading global supplier of this high-quality material necessary for this essential battery component.
This partnership allows ICL and OF&amp;EM to work together to advance electrification for both transportation and stationary applications and to bring the production of this critical component to North America. It will also enable them to optimize the performance, efficiency and safety of batteries used in consumer electronics, energy storage and other applications.

BMV:ORBIA

ICL Announced It Has Signed A MoU With Orbia Advance Corp., S.A.B. de C.V. Fluor & Energy Materials, As Both Companies Continue To Expand Their Presence In The North American Battery Materials Supply Chain

Biotech

SeaStar Medical Reports Strong Enrollment Progress In Pivotal Adult AKI Trial With 46 Total Subjects Enrolled; Trial Evaluates Safety And Efficacy Of Selective Cytopheretic Device For Acute Kidney Injury Patients In ICU

ICL Expands In China With New Food Specialty Plant In Zhangjiagang Free Trade Zone, Focuses On Innovative Solutions For Meat, Poultry, And Seafood Segments

Growing Solutions signs agreement with AMP Holdings Group for specialty water soluble fertilizers
ICL (NYSE:<a href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) (TASE: ICL), a leading global specialty minerals company, today announced it has signed a five-year agreement with AMP Holdings Group Co. Ltd., one of China's top agricultural distribution companies. The agreement, valued at approximately $170 million, will run until 2028 and advances ICL's stated goal to expand its Growing Solutions product offerings and to position the business for further growth in major end-markets.
The agreement is for specialty water soluble fertilizers, which are used in drip irrigation and designed for cash-crops, such as apples, watermelons, vegetables, strawberries, ginger and grapes. It includes a minimum purchase commitment, with certain exclusivity conditions based on brand and region.

ICL Signed A 5-Year Agreement With AMP Holdings Group Co, Continues Global Specialty Fertilizers Expansion With ~$170M Distribution Agreement In China

ICL Group Ltd&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/icl#NYSE">ICL</a>) recorded profits of $115 million or 9 cents per share in second-quarter 2024, down from $163 million or 13 cents in the year-ago quarter.
Barring one-time items, adjusted earnings per share were 10 cents. The bottom line beat the Zacks Consensus Estimate of 9 cents.
Sales fell around 6% yearly to $1,752 million in the quarter. The figure beat the Zacks Consensus Estimate of $1,733.2 million.
<div class="chart_embed">
<h3>ICL Group Ltd. Price, Consensus and EPS Surprise</h3>
<img alt="ICL Group Ltd. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/bc/1723803929.png" style="height:265px; width:570px" title="" />
ICL Group Ltd. price-consensus-eps-surprise-chart | ICL Group Ltd. Quote
</div>
<h3>Segment Highlights</h3>
Sales in the Industrial Products segment rose 5% year over year to $315 million in the quarter. EBITDA remained flat year over year at $74 million. This marks the third consecutive quarter of sequential EBITDA improvement, driven by ongoing cost-saving efforts and strengthening customer relationships.
Sales in the Potash segment dropped 27.5% year over year to $422 million in the said quarter. EBITDA also fell 44% year over year to $118 million.
Sales in the Phosphate Solutions segment inched up 1% year over year, reaching $572 million in the quarter. EBITDA rose 13% year over year to $146 million. This marks the second consecutive quarter of sequential sales improvement, with EBITDA up 11% sequentially. Pricing remained stable during the quarter, though evolving supply dynamics are anticipated to impact future performance.
Sales in the Growing Solutions segment rose 3% year over year to $494 million in the quarter. EBITDA nearly doubled from $22 million registered in the same period last year to $45 million.
<h3>Financials</h3>
At the end of the quarter, ICL had cash and cash equivalents of $287 million, down around 23% year over year. Long-term debt was $1,850 million, down nearly 13% year over year.
Cash provided by operating activities was $316 million in the reported quarter.
<h3>Guidance</h3>
The company updated its full-year 2024 guidance, now projecting specialties-driven EBITDA of $0.8 billion to $1 billion, compared with the previous guidance of $0.7 billion to $0.9 billion. The expected potash sales volumes remain unchanged in the range of 4.6-4.9 million metric tons.
<h3>Price Performance</h3>
ICL&#39;s shares have lost 31.1% in the past year compared with a 23.9% decline in the&nbsp;industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/18/74444.jpg?v=1004147804" />
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Key Picks</h3>
ICL currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Newmont Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nem#NYSE">NEM</a>), Franco-Nevada Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fnv#NYSE">FNV</a>) and Agnico Eagle Mines Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aem#NYSE">AEM</a>). Newmont and Franco-Nevada sport a Zacks Rank #1 (Strong Buy), and Agnico Eagle carries a Zacks Rank #2 (Buy).
The Zacks Consensus Estimate for Newmont&#39;s current-year earnings is pegged at $2.82, indicating a rise of 75% from year-ago levels. The consensus estimate for NEM&#39;s earnings has increased 16% in the past 60 days.The stock has gained nearly 28.8% in the past year.
The Zacks Consensus Estimate for FNV&#39;s current-year earnings is pegged at $3.27. The consensus estimate for FNV&#39;s earnings has increased by 3% in the past 60 days. FNV beat the consensus estimate in the last four quarters, with the average earnings surprise being 10.5%.
The Zacks Consensus Estimate for AEM&#39;s current fiscal year earnings is pegged at $3.65, indicating a year-over-year rise of 63.7%. AEM&#39;s earnings beat the Zacks Consensus Estimate in all of the last four quarters, the average earnings surprise being 15.7%. The company&#39;s shares have increased 70% in the past year.
<a href="https://www.zacks.com/stock/news/2323338/icl-group-s-icl-earnings-and-revenues-beat-estimates-in-q2?cid=CS-BENZ-FT-analyst_blog|earnings_article-2323338">To read this article on Zacks.com click here.</a>

Large Cap

Mid Cap

Penny Stocks

Trading Ideas

ICL Group's Earnings and Revenues Beat Estimates in Q2

Barclays analyst Benjamin Theurer maintains ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) with a Underweight and lowers the price target from $4.5 to $4.

Barclays Maintains Underweight on ICL Group, Lowers Price Target to $4

ICL shares are trading higher after the company raised FY24 guidance.

The company raised its guidance for full year 2024 and now expects specialties-driven EBITDA of between $0.8 billion to $1.0 billion, an increase from previous guidance of $0.7 billion to $0.9 billion, without any change to expected potash sales volumes

ICL Raised Its 2024 Guidance For Specialties-Driven EBITDA To $0.8B-$1B, From $0.7B-$0.9B

ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.09 by 11.11 percent. This is a 23.08 percent decrease over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $1.752 billion which missed the analyst consensus estimate of $1.759 billion by 0.40 percent. This is a 4.26 percent decrease over sales of $1.830 billion the same period last year.

ICL Group Q2 2024 Adj. EPS $0.10 Beats $0.09 Estimate, Sales $1.752B Miss $1.759B Estimate

U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Monday.
Shares of Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) fell in today&#8217;s pre-market trading after the company was ordered to pay $495 million in damages in its baby formula case.
Abbott shares lost 6.6% to $98.29 in pre-market trading
<ul>
<li>Integra LifeSciences Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) dipped 20.5% to $25.00 in pre-market trading after the company reported second-quarter results and lowered its FY24 outlook.</li>
<li>NewAmsterdam Pharma Company N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMS#NASDAQ">NAMS</a>) fell 13.8% to $16.26 in pre-market trading as the company announced topline data from pivotal Phase 3 BROOKLYN clinical trial evaluating Obicetrapib in patients wth Heterozygous Familial Hypercholesterolemia.</li>
<li>EZCORP, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) shares declined 8.8% to $9.41 in pre-market trading.</li>
<li>GeoPark Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPRK#NYSE">GPRK</a>) shares fell 6.5% to $9.52 in pre-market trading. GeoPark, last week, issued second quarter operational update.</li>
<li>Immutep Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) shares dipped 6.5% to $2.03 in pre-market trading. Immutep, last week, announced successful meeting with the FDA on Phase III design in non-small cell lung cancer.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) shares fell 5.4% to $8.75 in pre-market trading.</li>
<li>ICL Group Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) shares fell 4.1% to $4.43 in pre-market trading. ICL will release second quarter results before the opening of the TASE market on Wednesday, Aug. 14.</li>
<li>PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) slipped 3% to $126.84 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984123/jim-cramer-is-mystified-by-five-below-predicts-crowdstrike-is-going-to-bottom-here">Jim Cramer Is &#8216;Mystified&#8217; By Five Below, Predicts CrowdStrike &#8216;Is Going To Bottom Here&#8217;</a></li>
</ul>

Pre-Market Outlook

Movers

EZPW

GPRK

IART

IMMP

IOVA

NAMS

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Press Releases

ICL Reports Third Quarter 2024 Results

Small Cap

Israel Corp. Reports Results for Third Quarter of 2024

ICL Announces Planned Departure of President and CEO Raviv Zoller

ICL Unveils Breakthrough in Flame Retardant Technology

ICL Announces Follow-On Investment in Plantible Foods and Celebrates Industry Recognition for Innovative Food Ingredient

ICL Announces Appointment of Elad Aharonson as New President and Chief Executive Officer

ICL Signs Strategic Agreement with Dynanonic to Produce Lithium Iron Phosphate for European Battery Market

ICL Announces Fourth Quarter 2024 Earnings Call

GROWERS Revolutionizes Agriculture Loyalty Program Through Use of AI

ICL to Participate in Fireside Chat at Bank of America 2025 Global Agriculture and Materials Conference

Comments

ICL Group

매도 수량

ICL Group (NYSE:ICL) 주식, 공매도 수량 보고

뉴스

파트너 / 기고자

벤징가 글로벌